Journal article Open Access

A REVIEW ON PHARMACO KINETIC DRUG INTERACTIONS OF STATINS

A Satishchandra*, P Sureshkumar, V Radhika, T Anitha Chowdary. V. Jagannath Patro, A Sireesha

The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally well tolerated as monotherapy. Statins are associated with two important adverse effects, asymptomatic elevation in liver enzymes and myopathy. Myopathy is most likely to occur when statins are administered with other drugs. Statins are substrates of multiple drug transporters (including OAT- -P1B1, BCRP and MDR1) and several cytochrome P450 (CYP) enzymes (including CYP3A4, CYP2C8, CYP2C19, and CYP2C9). Possible adverse effects of statins can occur due to interactions in concomitant use of drugs that substantially inhibit or induce their methabolic pathway. This review aim is to summarize the most important interactions of statins.

Files (538.3 kB)
Name Size
29.pdf
md5:c7960b0363ce66163922ee9581cff7d6
538.3 kB Download
16
9
views
downloads
All versions This version
Views 1616
Downloads 99
Data volume 4.8 MB4.8 MB
Unique views 1414
Unique downloads 99

Share

Cite as